SCHEMBL19788083

SCHEMBL19788083

CC(CCO)(C[C@@H](Cc1ccc(-c2cc(Cl)ccc2F)cc1)NC(=O)c1cc(O)no1)C(=O)O

nearest known ligand 0.56

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
MME P08473 19/20 0.56
MMEL1 Q495T6 1/20 0.50
ACE P12821 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24350779 1.00 MME (0.56) MMEMMEL1ACE
SCHEMBL20681821 0.93 MME (0.57) MMEMMEL1ACE
SCHEMBL15467594 0.93 MME (0.57) MMEMMEL1ACE
SCHEMBL21350801 0.93 MME (0.54) MMEMMEL1ACE
SCHEMBL20681840 0.93 MME (0.54) MMEMMEL1ACE
SCHEMBL22019784 0.91 MME (0.54) MMEMMEL1ACE
SCHEMBL25913677 0.91 MME (0.54) MMEMMEL1ACE
SCHEMBL15472726 0.90 MME (0.54) MMEMMEL1ACE
SCHEMBL19788100 0.90 MME (0.54) MMEMMEL1ACE
SCHEMBL19687915 0.90 MME (0.69) MMEMMEL1ACE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9873685-B2 Neprilysin inhibitors THERAVANCE BIOPHARMA R&D IP, LLC (US) 2018-01-23 US disclosed